Andrea Necchi, MD

Andrea Necchi, MD, is an associate professor of oncology at Vita-Salute San Rafaelle University and director of genitourinary oncology at San Raffaele Hospital in Milan, Italy.

Articles by Andrea Necchi, MD

Dr Necchi on TAR-200 & Cetrelimab in Bladder Cancer

ByAndrea Necchi, MD

October 30th 2025

A new study reveals that combining TAR-200 with cetrelimab significantly improves treatment outcomes for muscle-invasive bladder cancer patients.

Can Targeted Therapy Revolutionize MIBC Treatment?

ByAndrea Necchi, MD

September 17th 2024

Andrea Necchi, MD, discusses how the findings from SunRISe-4 impact other data from the SunRISe group of clinical trials.

Andrea Necchi, MD

Articles by Andrea Necchi, MD

Dr Necchi on TAR-200 & Cetrelimab in Bladder Cancer

Can Targeted Therapy Revolutionize MIBC Treatment?

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma

Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update